Overview

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

Status:
Not yet recruiting
Trial end date:
2024-04-04
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the safety and efficacy of OK-101 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Phase:
Phase 2
Details
Lead Sponsor:
Okyo Pharma Ltd
Collaborator:
ORA, Inc.